Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2007 | 1 |
2015 | 1 |
2017 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Quoted phrase not found in phrase index: "Gaucher disease type 3A"
Page 1
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.
Int J Mol Sci. 2017 Feb 17;18(2):441. doi: 10.3390/ijms18020441.
Int J Mol Sci. 2017.
PMID: 28218669
Free PMC article.
Review.
Gaucher disease (GD, ORPHA355) is a rare, autosomal recessive genetic disorder. ...Type-1 Gaucher disease, which affects the majority of patients (90% in Europe and USA, but less in other regions), is characterized by effects on the viscera, whe …
Gaucher disease (GD, ORPHA355) is a rare, autosomal recessive genetic disorder. ...Type-1 Gaucher disease …
Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
Choy FY, Zhang W, Shi HP, Zay A, Campbell T, Tang N, Ferreira P.
Choy FY, et al.
Blood Cells Mol Dis. 2007 May-Jun;38(3):287-93. doi: 10.1016/j.bcmd.2006.11.003. Epub 2006 Dec 29.
Blood Cells Mol Dis. 2007.
PMID: 17196853
Review.
Three clinical forms of Gaucher disease have been described: Type 1 non-neuronopathic, Type 2 acute neuronopathic, and Type 3 subacute neuronopathic. ...With the exception of N370S and R353W found only in the Type 1 form, the majority of …
Three clinical forms of Gaucher disease have been described: Type 1 non-neuronopathic, Type 2 acute neuronopathi …
Item in Clipboard
Impact of imiglucerase supply constraint on the therapeutic management and course of disease in French patients with Gaucher disease type 1.
Stirnemann J, Rose C, Serratrice C, Dalbies F, Lidove O, Masseau A, Pers YM, Baron C, Belmatoug N.
Stirnemann J, et al.
Orphanet J Rare Dis. 2015 May 13;10:62. doi: 10.1186/s13023-015-0275-0.
Orphanet J Rare Dis. 2015.
PMID: 25968608
Free PMC article.
BACKGROUND: In 2009, a worldwide supply constraint of imiglucerase led to treatment modifications or interruptions for patients with Gaucher disease (GD) type 1. In France, joint treatment recommendations were issued to protect the most vulnerable patients. T …
BACKGROUND: In 2009, a worldwide supply constraint of imiglucerase led to treatment modifications or interruptions for patients with Gauc …
Item in Clipboard
Cite
Cite